Pancreatic Cancer Research

ResearcherOsaka International Cancer InstituteActive in the last 2 years

Arata Sakai

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1072-5243; OpenAlex author ID A5001587907. Sources: OpenAlex.

Their work

Papers
18
Trials
0
Grants
0
Labs led
0
Collaborators
44
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 5 papers · 2024: 4 papers · 2025: 1 paper · 2026: 2 papers

Papers 18

  1. Biological Borderline Resectable Pancreatic Cancer Represents a Genetically and Immunologically Aggressive Subtype: A Retrospective Study. Co-author DOI 10.1097/sla.0000000000007075↗
  2. Deep Learning Detection of Direct and Indirect Imaging Findings Associated with Pancreatic Cancer at Contrast-enhanced and Noncontrast CT. Co-author DOI 10.1148/radiol.253122↗
  3. Multicenter Comparative Study of 6- and 10-mm Fully Covered Self-Expandable Metal Stents for Malignant Distal Biliary Obstruction During Neoadjuvant Chemothera… Co-author DOI 10.1002/jhbp.12157↗
  4. Temporal progression of pancreatic cancer computed tomography findings until diagnosis: A large-scale multicenter study. Co-author DOI 10.1002/ueg2.12557↗
  5. Impact of intratumoral microbiome on tumor immunity and prognosis in human pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00535-023-02069-5↗
  6. Association of pancreatic atrophy patterns with intraductal extension of early pancreatic ductal adenocarcinoma: a multicenter retrospective study. Co-author DOI 10.1007/s00535-024-02149-0↗
  7. Treatment and Prognosis for Pancreatic Duct Disruption Associated With Pancreatic Cancer: A Case Series of 15 Patients. Co-author DOI 10.7759/cureus.67482↗
  8. Integrated analysis of tertiary lymphoid structures in relation to tumor-infiltrating lymphocytes and patient survival in pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00535-022-01939-8↗
  9. A comprehensive analysis of tumor-stromal collagen in relation to pathological, molecular, and immune characteristics and patient survival in pancreatic ductal… Co-author DOI 10.1007/s00535-023-02020-8↗
  10. A case of pancreatic ductal adenocarcinoma concomitant with IgG4-related disease in the pancreas and the stomach. Co-author DOI 10.1007/s12328-023-01814-w↗
  11. Benefits of pancreatic parenchymal endoscopic ultrasonography in predicting microscopic precancerous lesions of pancreatic cancer. Co-author DOI 10.1038/s41598-023-38920-1↗
  12. Association of Sarcopenia with a Poor Prognosis and Decreased Tumor-Infiltrating CD8-Positive T Cells in Pancreatic Ductal Adenocarcinoma: A Retrospective Anal… Co-author DOI 10.1245/s10434-023-13569-2↗
  13. Comprehensive Analysis of Molecular Biologic Characteristics of Pancreatic Ductal Adenocarcinoma Concomitant with Intraductal Papillary Mucinous Neoplasm. Co-author DOI 10.1245/s10434-022-11704-z↗
  14. Prospective Study Using Plasma Apolipoprotein A2-Isoforms to Screen for High-Risk Status of Pancreatic Cancer. Co-author DOI 10.3390/cancers12092625↗
  15. Multifocal cysts and incidence of pancreatic cancer concomitant with intraductal papillary mucinous neoplasm. Co-author DOI 10.1016/j.pan.2018.04.005↗
  16. Pancreatic cancer screening using a multiplatform human serum metabolomics system. Co-author DOI 10.2217/bmm-2016-0020↗
  17. Effectiveness of endoscopic self-expandable metal stent placement for afferent loop obstruction caused by pancreatic cancer recurrence after pancreaticoduodene… Co-author DOI 10.1007/s12328-015-0556-0↗
  18. Risk of peritoneal carcinomatosis by endoscopic ultrasound-guided fine needle aspiration for pancreatic cancer. Co-author DOI 10.1007/s00535-012-0693-x↗

Closest collaborators

The 25 strongest of 44 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Atsuhiro Masuda · 15 shared papers, 2018–2026 · strength 2.22
  2. Takashi Kobayashi · 15 shared papers, 2015–2026 · strength 1.88
  3. Yuzo Kodama · 12 shared papers, 2020–2025 · strength 1.76
  4. Masanori Gonda · 11 shared papers, 2022–2026 · strength 1.66
  5. Hirochika Toyama · 11 shared papers, 2018–2024 · strength 1.49
  6. Keitaro Sofue · 10 shared papers, 2018–2026 · strength 1.40
  7. Takumi Fukumoto · 10 shared papers, 2018–2026 · strength 1.38
  8. Masahiro Tsujimae · 9 shared papers, 2022–2026 · strength 1.30
  9. Mika Miki · 8 shared papers, 2023–2026 · strength 1.26
  10. Kohei Yamakawa · 7 shared papers, 2022–2024 · strength 0.94
  11. Shohei Abe · 7 shared papers, 2022–2024 · strength 0.94
  12. Takeshi Tanaka · 7 shared papers, 2022–2024 · strength 0.93
  13. Tomoo Itoh · 7 shared papers, 2022–2024 · strength 0.93
  14. Yoshiyuki Harada · 6 shared papers, 2023–2026 · strength 0.90
  15. Shigeto Ashina · 6 shared papers, 2022–2026 · strength 0.81
  16. Ryota Nakano · 5 shared papers, 2022–2025 · strength 0.79
  17. Shigeto Masuda · 6 shared papers, 2022–2024 · strength 0.76
  18. Mamoru Takenaka · 5 shared papers, 2015–2025 · strength 0.65
  19. Takuya Ikegawa · 5 shared papers, 2018–2026 · strength 0.65
  20. Yuichi Hirata · 3 shared papers, 2016–2026 · strength 0.41
  21. Yoshihide Nanno · 2 shared papers, 2023–2026 · strength 0.33
  22. Yuki Oka · 2 shared papers, 2024 · strength 0.31
  23. Tsuyoshi Hamada · 2 shared papers, 2023 · strength 0.25
  24. Masaru Yoshida · 3 shared papers, 2016–2020 · strength 0.21
  25. Takayuki Kodama · 1 shared paper, 2026 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.